Estimating Utilities / Disutilities for High Risk Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) and Treatment-Related Adverse Events

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.282
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy